abstract |
The present invention relates to a novel 6-heteroarylamino-2,4,5-trimethylpyridin-3-ol compound, or a pharmaceutically acceptable salt thereof. Specifically, the present invention is a novel 6-heteroarylamino-2,4,5-trimethylpyridin-3-ol compound having an effect of preventing or treating inflammatory bowel disease and autoimmune diseases, or pharmaceutically acceptable thereof It relates to possible salts. |